Infographic: Patient Concerns With Biosimilar Substitution

A recent survey of 588 Canadian patients revealed that many patients had serious concerns about biosimilar substitution. 
The Center for Biosimilars Staff
August 06, 2017
A recent survey of 588 Canadian patients revealed that many patients had serious concerns about biosimilar substitution. 

infographic showing patient concerns about automatic substitution of biosimilars

x-button

Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright © 2006-2019 Intellisphere, LLC. All Rights Reserved.